Pages that link to "Q41655828"

The following pages link to Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses (Q41655828):

Displaying 46 items.

• Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes (Q36365159) (← links)
• B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes (Q36365932) (← links)
• Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo (Q36367135) (← links)
• Costimulation by B7 modulates specificity of cytotoxic T lymphocytes: a missing link that explains some bystander T cell activation. (Q36380864) (← links)
• Tumor-infiltrating T lymphocytes: friends or foes? (Q36381918) (← links)
• Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells. (Q36599550) (← links)
• The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity (Q36674612) (← links)
• A soluble, single-chain Kd molecule produced by yeast selects a peptide repertoire indistinguishable from that of cell-surface-associated Kd. (Q36766284) (← links)
• Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines (Q37140636) (← links)
• Korean Red Ginseng water extract arrests growth of xenografted lymphoma cells (Q37314419) (← links)
• Peptide-based vaccines for cancer: realizing their potential (Q37340462) (← links)
• T cell mediated suppression of neurotropic coronavirus replication in neural precursor cells (Q37489374) (← links)
• Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6. (Q38299305) (← links)
• Lymph formation, composition and circulation: a proteomics perspective (Q38383566) (← links)
• Development of Peptide Vaccines in Dengue. (Q40038715) (← links)
• Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice. (Q40041611) (← links)
• Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen (Q40245988) (← links)
• Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules (Q40813334) (← links)
• Is there a future for extracorporeal photochemotherapy in the treatment of the rheumatological diseases? (Q40892440) (← links)
• combination therapy with fumagillin and vaccination with tumor-derived antigenic peptides in B16 melanoma-transplanted mice. (Q41013617) (← links)
• Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors (Q41304280) (← links)
• Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised (Q41342823) (← links)
• Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic (Q41373011) (← links)
• A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen (Q41426185) (← links)
• In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells (Q41434481) (← links)
• In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. (Q41529681) (← links)
• Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells (Q41532466) (← links)
• Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes (Q41552347) (← links)
• In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides (Q41591563) (← links)
• Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses (Q41595705) (← links)
• Cytotoxic T lymphocytes against the antigen-processing-defective RMA-S tumor cell line (Q41620803) (← links)
• Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity (Q41646149) (← links)
• The lymph as a pool of self-antigens (Q42672113) (← links)
• Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. (Q42943391) (← links)
• Carrying yourself: self antigen composition of the lymphatic fluid. (Q44261970) (← links)
• Delayed progression of murine AIDS in C57BL/6 mice pre-immunized with a highly antigenic 10-mer peptide encoded by the murine AIDS defective virus gag p12 gene (Q45753078) (← links)
• A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma. (Q45872230) (← links)
• Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime-boost immunization (Q47601205) (← links)
• Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. (Q47999007) (← links)
• Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface. (Q54009058) (← links)
• Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines (Q56967695) (← links)
• Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells (Q70493692) (← links)
• Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro (Q71696210) (← links)
• Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4+ T-cell help (Q71764415) (← links)
• Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca (Q72333329) (← links)
• Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination (Q72966503) (← links)